Skip to content

Tissue Engineering for Hair Follicle Regeneration

Study of Tissue Engineering for Hair Follicle Regeneration

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00506636
Enrollment
400
Registered
2007-07-25
Start date
2006-05-31
Completion date
2016-12-31
Last updated
2007-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair Follicle Regeneration, Tissue Engineering

Brief summary

This study is to try to maintain cultured dermal papilla cells in spherical structure in vitro before transplanting into dermis in vivo. Also, this study is aimed in clarifying actual mechanism of inducing hair follicle by dermal papilla cells.

Detailed description

Hair transplantation is an well-documented way of treating hair loss. Hair transplantation is based on redistribution of hair follicles without any new follicle formation. It has been long that a lot of researchers have focused on developing skills in regenerating hair follicles. However, cultured dermal papilla cells lose the ability of inducing hair follicle formation after several generations in vitro culture. Our study is aiming in culturing dermal papilla cells in vitro and maintain their spherical structure before transplanting into dermis in vivo. Meantime, this study may help clarify the actual mechanism of inducing hair follicle by dermal papilla cells.

Interventions

BEHAVIORALTissue engineering for hair follicle regeneration

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
National Health Research Institutes, Taiwan
CollaboratorOTHER
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
NATURAL_HISTORY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients receiving cosmetic surgeries such as removal of moles

Exclusion criteria

* No special

Countries

Taiwan

Contacts

Primary ContactSung-Jan Lin, MD PhD
jsjl2000tw@yahoo.com.tw+886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026